Clinical Trials Database

Protocol	Title
BERLEXWIRB	A Phase II study to investigate the efficacy and safely of ZK-Epothilone (ZK-EPO); in patients with metastatic breast cancer.
B-36	A Clinical Trial of Adjuvant Therapy Comparing 6 Cycles of 5-FU, Epirubicin, and Cyclophosphamide (FEC) to 4 Cycles of Adriamycin and Cyclophosphamide (AC) with or without Celecoxib, in Patients with Node-Negative Breast Cancer
NSABPB-40	A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel when Administered Before AC with or without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR with Each of the Regimens.
PACCT-1	(Program for the Assessment of Clinical Cancer Tests) - ER-Positive and/or PR-Positive Breast Cancer Axillary Node-Negative Candidate for Adjuvant Cytotoxic Therapy in Addition to Hormonal Therapy.
N0147	Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225)after Curative resection for Patients with Stage III Colon Cancer.
ET743-SAR-3002	A multicenter, open-label single-arm study of YONDELIS (trabectedin) for subjects with locally advanced or metastatic soft tissue sarcoma who have relapsed or are refractory to standard of care treatment.
CTSUECOG1302	A Randomized Phase III Trial, placebo controlled, of docetaxel versus docetaxel plus ZD1839 in performance status 2 or previously treated patients with recurrent or Metastatic head and neck cancer.
GENENTECHAVF3671g	A randomized, double-blind, placebo-controlled, phase IIIb trial comparing Bevacizumab therapy with or without Erolotinib after completion of chemotherapy with Bevacizumab for the first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer.